Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01144104 · ClinicalTrials.gov registry record · NA
Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness Study
A NA study of Depression, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 925
- Enrollment target
- 6
- Study locations
NCT01144104 is a NA study of Depression that has completed, run by University of California, Davis. The registered enrollment target is 925 participants, above the 785-participant average among 679 other Depression trials with a reported enrollment target (18% higher). The trial reports 6 study locations across 1 state.
The verdict
NCT01144104, a NA study of Depression, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 925 participants
- Enrollment target
- 6
- Study locations
Study Summary
This trial consists of two linked substudies. Substudy 1: Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness Study Substudy 2: Activating Messages for Enhancing Primary Care Practice (AMEP2): Toxicity Study The purpose of the Effectiveness Study is to assess the comparative effectiveness of three multimedia educational interventions (a targeted educational video, a tailored interactive multimedia computer program, and an "attention control") for increasing the likelihood that primary care patients with significant depressive symptoms will seek appropriate care (n = 510). The primary study outcomes are provision of minimally acceptable initial care, reductions in depression-related stigma, and improvement in depression symptoms. (See Process of Care and Patient Outcomes in Primary Outcome Measure section.) The purpose of the Toxicity Study is to assess the potential benefits (reduced stigma) and harms (inappropriate prescribing) associated with three multimedia depression educational interventions when administered to patients with few or no depressive symptoms (n = 308). The primary outcomes relating to this outcome are reducing depression-related stigma and reducing unnecessary prescribing. (See Toxicity in Primary Outcome Measure section.) Both studies will look at the secondary outcome measure of patient requests for depression treatment.
Conditions Studied
Interventions
- BEHAVIORAL Public Service Announcement
- BEHAVIORAL Interactive Multi-Media Computer Program
- BEHAVIORAL Sleep Hygiene Video
Study Locations (6)
California
- Sutter Health - Elk Grove Family Medicine - Elk Grove
- VA Northern California Healthcare System - Mather
- Kaiser Permanente - Point West - Sacramento
- University of California, Davis - Sacramento
- San Francisco VA Medical Center - San Francisco
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 925 participants |
| Start Date | 2010-06 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01144104
The ClinicalTrials.gov registry entry for NCT01144104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 925 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 785-participant average among 679 other Depression trials with a reported enrollment target (18% higher). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Public Service Announcement is the first listed.
NCT01144104 reports 6 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01144104 about?
NCT01144104 is a clinical study titled "Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness Study". This trial consists of two linked substudies. Substudy 1: Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness Study Substudy 2: Activating Messages for Enhancing Primary Care Practice (AMEP2): Toxicity Study The purpose of the Effectiveness Study is to assess the compar...
What is the current status of trial NCT01144104?
This trial is currently completed. It is a NA study. The enrollment target is 925 participants. The study started on 2010-06. Estimated completion is 2014-06.
What conditions does trial NCT01144104 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT01144104?
The interventions under investigation include: Public Service Announcement (BEHAVIORAL), Interactive Multi-Media Computer Program (BEHAVIORAL), Sleep Hygiene Video (BEHAVIORAL).
Who is sponsoring clinical trial NCT01144104?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01144104 being conducted?
This trial has 6 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.